Quarterly Result30 Jan 2026, 05:15 pm
Insecticides (India) Ltd Reports 8% Revenue Growth in Q3 FY26 Despite Challenging Environment
AI Summary
Insecticides (India) Limited, a leading crop protection and nutrition company, has announced its financial results for the quarter and nine months ended December 31, 2025. The company reported an 8% increase in revenue from operations in Q3 FY26, primarily driven by the B2B segment. However, B2C sales were impacted by macro industry headwinds. The company launched five new products during 9MFY26 and continues to invest in long-term brand building. The company's MD, Rajesh Kumar Aggarwal, expressed confidence in the company's ability to deliver profitable growth over the medium term.
Key Highlights
- Revenue grew by 8% in Q3, primarily driven by robust performance in the B2B segment.
- New product launches, including Sparcle, Centran and Torry Super, witnessed encouraging farmer adoption.
- Gross profit margins moderated in Q3 FY26, driven by a higher B2B mix and industry-led pressure on B2C margins.
- Increase in finance cost and depreciation impacted PAT growth in Q3FY26 as compared to Q3 FY25.
- Company continues to invest in long-term brand building and farmer engagement.